Study for continued access to dacomitinib for patients previously treated with dacomitinib in clinical studies in Japan
Treatment Access Protocol for Patients Previously Treated With Dacomitinib on a Clinical Trial in Japan
Category & Conditions: Cancer
Medicine: VIZIMPRO® TABLETS(DACOMITINIB)
ClinicalTrials.gov Identifier (NCT): NCT02382796
Protocol ID: A7471055
PrintDownloadOpen Plain Language Summary Result: Click here